Austin Health

Title
Precipitating hydrophobic injectable liquid (PHIL) embolic for the treatment of a uterine arteriovenous malformation: a technical report.
Publication Date
2019-05-17
Author(s)
Kurda, Dylan
Guduguntla, Geetha
Maingard, Julian T
Kok, Hong Kuan
Lalloo, Shivendra
Subject
AVM
Embolization
PHIL
Uterine artery
Type of document
Journal Article
OrcId
0000-0001-5637-734X
0000-0001-8958-2411
DOI
10.1186/s42155-019-0059-z
Abstract
Uterine arteriovenous malformations (AVM) are unusual causes of vaginal bleeding. Although hysterectomy is the definitive treatment; uterine artery embolization (UAE) provides an alternative therapeutic option. This case presents a technical report of a uterine AVM treated successfully with transcatheter UAE using precipitating hydrophobic injectable liquid (PHIL) embolic agent. A 41-year-old female, gravida 6, para 4, miscarriage 2, including a molar pregnancy 15 years prior, presented with massive per vaginal bleeding. Pelvic ultrasound demonstrated an acquired AVM as the underlying aetiology for her presentation. The patient underwent bilateral uterine arterial embolization. Four weeks later, there was nearly complete resolution of the AVM and the patient's menstrual cycle was restored 8 weeks after the procedure. Uterine AVM can be treated safely and effectively with UAE using PHIL.
Link
Citation
CVIR endovascular 2019; 2(1): 17
Jornal Title
CVIR endovascular

Files:

NameSizeformatDescriptionLink